A 35-year-old woman from rural Maharashtra is diagnosed with TB and classified as a new case under RNTCP. Which feature would best distinguish her from a TB patient classified as a 'previously treated' case for the purpose of anti-TB drug regimen assignment?

## RNTCP Case Classification: New vs. Previously Treated ### Definition and Clinical Significance **Key Point:** Under RNTCP, the **primary discriminator between a 'new' TB case and a 'previously treated' case is prior anti-TB treatment history of ≥1 month**, regardless of treatment outcome. This classification directly determines the anti-TB drug regimen assigned. ### RNTCP Case Classification Framework | Classification | Definition | Anti-TB Regimen | Rationale | |---|---|---|---| | **New case** | No prior anti-TB treatment, or <1 month of prior treatment | Category I (2HRZE/4HR) | Assumes drug-susceptible TB; standard first-line regimen | | **Previously treated** | ≥1 month of prior anti-TB treatment | Category II (2HRZES/1HRZE/5HR) or Category IV (for MDR-TB) | Higher risk of drug resistance; requires extended intensive phase and fluoroquinolone | | **Treatment after loss to follow-up (LTFU)** | Interrupted treatment, then restarted | Category II or III (depends on duration) | Risk of resistance; requires assessment | | **Treatment failure** | Persistent smear-positive after 5 months of Category I | Category II or IV | High risk of MDR-TB | ### Why Prior Treatment History is the Discriminator 1. **Drug resistance risk:** Patients with prior treatment exposure have higher rates of drug-resistant TB (DR-TB), necessitating a more intensive regimen. 2. **Regimen assignment:** RNTCP explicitly uses prior treatment history as the primary criterion for regimen selection, not clinical or radiological features. 3. **Operational clarity:** Treatment history is objective and verifiable; it does not depend on interpretation of imaging or smear status. 4. **Public health strategy:** Identifying previously treated cases allows targeted surveillance for drug resistance and appropriate case management. **High-Yield:** The threshold is **≥1 month of prior anti-TB treatment**. A patient with <1 month of prior treatment is still classified as "new" and receives Category I regimen. **Mnemonic:** **RNTCP Case Classification = Treatment History First** - **New:** No prior Rx or <1 month - **Previously treated:** ≥1 month prior Rx (any outcome) - **Regimen depends on classification**, not on smear status or X-ray findings **Clinical Pearl:** A patient who received 3 months of anti-TB therapy, defaulted, and now presents with recurrent TB is classified as "previously treated" and receives Category II regimen, even if sputum smear is negative at re-presentation.